- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 27.32M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 27.86M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 28.11M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $25.18M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $16.87M |
| Capex | Q1 2026 · Mar 31, 2025 | $9.9M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $34.5M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $31.12M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $22.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $533.92M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $581.83M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $497.85M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $133.69M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $78.79M |
| Current Liabilities | Q1 2026 · Mar 31, 2025 | $91.72M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $393.25M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $305.04M |
| Total Liabilities | Q1 2026 · Mar 31, 2025 | $243.22M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $205.39M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $63.66M |
| Current Assets | Q1 2026 · Mar 31, 2025 | $100.05M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $965.43M |
| Total Assets | Q1 2026 · Mar 31, 2025 | $832.56M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.90 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.11 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.90 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.11 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $19.21M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $20.69M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$24.94M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$31.14M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.99M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.29M |
| Revenue | Q1 2026 · Mar 31, 2026 | $51.64M |
| Revenue | Q1 2026 · Mar 31, 2025 | $37.58M |